These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8883264)

  • 1. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
    Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
    Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis.
    Zheng YN; Yu HJ; Hou JX; Lu CF; Zhou J
    Chin Med J (Engl); 2009 Jul; 122(14):1674-80. PubMed ID: 19719970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation.
    Helley D; Girot R; Guillin MC; Bezeaud A
    Br J Haematol; 1997 Nov; 99(2):268-72. PubMed ID: 9375737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Ca(2+)-containing vesicles in sickle cell disorders.
    Westerman MP; Puchulu E; Schlegel RA; Salameh M; Williamson P
    J Lab Clin Med; 1994 Sep; 124(3):416-20. PubMed ID: 8083584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased procoagulant activity of red blood cells in the presence of cisplatin.
    Lü CF; Yu HJ; Hou JX; Zhou J
    Chin Med J (Engl); 2008 Sep; 121(18):1775-80. PubMed ID: 19080356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical characterization of beta-thalassemic red blood cells.
    Desouky OS; Selim NS; El-Bakrawy EM; El-Marakby SM
    Cell Biochem Biophys; 2009; 55(1):45-53. PubMed ID: 19585085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia.
    Bunyaratvej A; Fucharoen S; Butthep P; Sae-ung N; Kamchonwongpaisan S; Khuhapinant A
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():257-60. PubMed ID: 8629118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
    Morris CL; Gruppo RA; Shukla R; Rucknagel DL
    J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
    Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C.
    Bezeaud A; Venisse L; Helley D; Trichet C; Girot R; Guillin MC
    Br J Haematol; 2002 May; 117(2):409-13. PubMed ID: 11972526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered sialic acid contents of red blood cell membrane preparations in homozygous beta-thalassemia.
    Calatroni A; Barberi I; Salpietro C
    Ital J Biochem; 1978; 27(2):94-103. PubMed ID: 730497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells.
    Butthep P; Wanram S; Pattanapanyasat K; Vattanaviboon P; Fucharoen S; Wilairat P
    Cytometry B Clin Cytom; 2006 Nov; 70(6):432-42. PubMed ID: 16977636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rat model for sickle cell-mediated vaso-occlusion in retina.
    Lutty GA; Phelan A; McLeod DS; Fabry ME; Nagel RL
    Microvasc Res; 1996 Nov; 52(3):270-80. PubMed ID: 8954868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
    Kean LS; Brown LE; Nichols JW; Mohandas N; Archer DR; Hsu LL
    Exp Hematol; 2002 May; 30(5):394-402. PubMed ID: 12031645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density distribution of red cells and prognostic significance in 50 patients with homozygous sickle-cell disease.
    Pajot N; Maier-Redelsperger M; Dode C; Labie D; Girot R
    Haematologia (Budap); 1988; 21(4):189-97. PubMed ID: 3209123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
    Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
    Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of hemostatic factors in patients with hemoglobinopathies.
    Oner AF; Gürgey A; Okur H; Kirazli S; Gümrük F; Altay C
    Turk J Pediatr; 1999; 41(3):323-7. PubMed ID: 10770092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.